Crossmark

Development of Azeliragon, an Oral Small Molecule Antagonist of the Receptor for Advanced Glycation Endproducts, for the Potential Slowing of Loss of Cognition in Mild Alzheimer's Disease

Crossref DOI link: https://doi.org/10.14283/jpad.2018.18

Published Print: 2018-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Burstein, A.H.

Sabbagh, M.

Andrews, R.

Valcarce, C.

Dunn, I.

Altstiel, Larry
License Information

Text and Data Mining valid from 2018-04-01

Text and Data Mining valid from 2018-04-01

Version of Record valid from 2024-09-26
More Information

This article is maintained by: Elsevier

Article Title: Development of Azeliragon, an Oral Small Molecule Antagonist of the Receptor for Advanced Glycation Endproducts, for the Potential Slowing of Loss of Cognition in Mild Alzheimer's Disease

Journal Title: The Journal of Prevention of Alzheimer's Disease

CrossRef DOI link to publisher maintained version: https://doi.org/10.14283/jpad.2018.18

Content Type: simple-article

Copyright: Copyright © 2018 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS

Document is current

Any future updates will be listed below